Kennedy, P. T. Et Al. 2023. EFFICACY AND SAFETY OF siRNA JNJ-73763989, CAPSID ASSEMBLY MODULATOR- E (CAM-E) JNJ - 56136379, AND NUCLEOS(T) IDE ANALOGS ( NA) WITH PEGYLATED INTERFERON ALPHA-2a (PEGIFN-α2a) ADDED IN IMMUNE - TOLERANT PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION: INTERIM RESULTS FROM THE PHASE 2 REEF- IT STUDY. Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) , (Massachusetts, United States Of America).

Kennedy, P. T., Fung, S. K., Buti, M., YILMAZ, G., Chuang, W. L., Asselah, T., ... Kurosaki, M.(2023). EFFICACY AND SAFETY OF siRNA JNJ-73763989, CAPSID ASSEMBLY MODULATOR- E (CAM-E) JNJ - 56136379, AND NUCLEOS(T) IDE ANALOGS ( NA) WITH PEGYLATED INTERFERON ALPHA-2a (PEGIFN-α2a) ADDED IN IMMUNE - TOLERANT PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION: INTERIM RESULTS FROM THE PHASE 2 REEF- IT STUDY . Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America

Kennedy, Patrick Et Al. "EFFICACY AND SAFETY OF siRNA JNJ-73763989, CAPSID ASSEMBLY MODULATOR- E (CAM-E) JNJ - 56136379, AND NUCLEOS(T) IDE ANALOGS ( NA) WITH PEGYLATED INTERFERON ALPHA-2a (PEGIFN-α2a) ADDED IN IMMUNE - TOLERANT PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION: INTERIM RESULTS FROM THE PHASE 2 REEF- IT STUDY," Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 2023

Kennedy, Patrick T. Et Al. "EFFICACY AND SAFETY OF siRNA JNJ-73763989, CAPSID ASSEMBLY MODULATOR- E (CAM-E) JNJ - 56136379, AND NUCLEOS(T) IDE ANALOGS ( NA) WITH PEGYLATED INTERFERON ALPHA-2a (PEGIFN-α2a) ADDED IN IMMUNE - TOLERANT PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION: INTERIM RESULTS FROM THE PHASE 2 REEF- IT STUDY." Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) , Massachusetts, United States Of America, 2023

Kennedy, P. T. Et Al. (2023) . "EFFICACY AND SAFETY OF siRNA JNJ-73763989, CAPSID ASSEMBLY MODULATOR- E (CAM-E) JNJ - 56136379, AND NUCLEOS(T) IDE ANALOGS ( NA) WITH PEGYLATED INTERFERON ALPHA-2a (PEGIFN-α2a) ADDED IN IMMUNE - TOLERANT PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION: INTERIM RESULTS FROM THE PHASE 2 REEF- IT STUDY." Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) , Massachusetts, United States Of America.

@conferencepaper{conferencepaper, author={Patrick T. Kennedy Et Al. }, title={EFFICACY AND SAFETY OF siRNA JNJ-73763989, CAPSID ASSEMBLY MODULATOR- E (CAM-E) JNJ - 56136379, AND NUCLEOS(T) IDE ANALOGS ( NA) WITH PEGYLATED INTERFERON ALPHA-2a (PEGIFN-α2a) ADDED IN IMMUNE - TOLERANT PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION: INTERIM RESULTS FROM THE PHASE 2 REEF- IT STUDY}, congress name={Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)}, city={Massachusetts}, country={United States Of America}, year={2023}}